Harbin Gloria Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 68.7% in First Three Quarters of 2022

Harbin Gloria Pharmaceuticals Co.,Ltd. (哈尔滨誉衡药业股份有限公司) (002437.SZ) reported a net profit of 37.3 million yuan in the first three quarters of 2022, down 68.7% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, up 4.2% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 2.5 billion yuan in total liabilities, with a liability-to-asset ratio of 55.4%.